论文部分内容阅读
恶性肿瘤仍然严重威胁人类健康。经过数十年发展,现有的抗肿瘤药物对大部分恶性肿瘤患者仍只能起到缓解病情的作用。在过去10年中,新靶点、新作用机制的抗肿瘤药物不断涌现,药物抗肿瘤效果不断增强,为临床应用提供了更多用药选择。本文就近10年美国FDA批准上市的抗肿瘤药物进行分类总结,分析了抗肿瘤药物的应用现状和发展趋势。
Malignant tumors are still a serious threat to human health. After decades of development, the existing antitumor drugs still can only relieve the condition of most malignant tumor patients. In the past 10 years, the new targets and new mechanisms of antitumor drugs continue to emerge, the antitumor effect of the drugs is continuously enhanced, and more options for clinical application are provided. This article summarizes the classification and classification of antitumor drugs approved by the US FDA in the recent 10 years and analyzes the current status and development trend of antitumor drugs.